Thyrocare Technologies Ltd

Thyrocare Tech. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Thyrocare Technologies Ltd

₹ 646 1.60%
22 Jul 4:01 p.m.
thyrocare.com BSE: 539871 NSE: THYROCARE
About

Thyrocare Technologies is engaged in the business of healthcare industry and is involved in providing quality diagnostic services at affordable costs to patients, laboratories and hospitals in India.

Key Points

World’s leading Diagnostic center Incorporated in the year 1996, as a single economical thyroid testing center in Mumbai and now has become the world's leading Diagnostic chain which offers a wide range of medical diagnostic tests and management of diseases and disorders. [1]

Website BSE NSE
  • Market Cap ₹ 3,424 Cr.
  • Current Price ₹ 646
  • High / Low ₹ 723 / 507
  • Stock P/E 49.3
  • Book Value ₹ 99.5
  • Dividend Yield 2.79 %
  • ROCE 17.8 %
  • ROE 13.1 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 109%
  • Debtor days have improved from 48.2 to 27.7 days.

Cons

  • The company has delivered a poor sales growth of 7.26% over past five years.
  • Promoters have pledged 100% of their holding.
  • Working capital days have increased from 62.5 days to 107 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
147 165 176 117 131 128 135 128 136 135 148 135 154
95 94 87 81 93 92 103 100 111 100 110 103 121
Operating Profit 52 71 89 37 38 36 32 28 25 35 38 32 34
OPM % 35% 43% 51% 31% 29% 28% 23% 22% 18% 26% 25% 23% 22%
4 10 15 1 3 1 2 3 4 1 3 3 3
Interest -0 1 1 0 1 1 1 1 1 1 1 1 1
Depreciation 8 7 8 9 10 9 9 10 11 10 11 13 13
Profit before tax 48 74 95 29 30 28 24 20 17 25 28 20 23
Tax % 21% 24% 19% 25% 29% 22% 35% 25% 28% 31% 28% 26% 25%
38 56 78 22 21 22 15 15 12 17 20 15 17
EPS in Rs 7.14 10.51 14.70 4.06 4.01 4.11 2.92 2.78 2.38 3.27 3.84 2.90 3.36
Raw PDF
Upcoming result date: tomorrow

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
183 241 304 356 403 434 495 589 527 572
110 147 189 212 249 261 323 353 403 434
Operating Profit 73 94 115 145 154 174 171 236 123 137
OPM % 40% 39% 38% 41% 38% 40% 35% 40% 23% 24%
8 7 -15 21 11 1 12 29 9 10
Interest 0 1 0 0 1 2 1 3 5 4
Depreciation 13 18 18 20 26 32 30 34 39 47
Profit before tax 68 82 82 145 138 140 152 228 89 96
Tax % 35% 37% 48% 36% 38% 37% 26% 23% 27% 28%
44 52 43 93 85 88 113 176 64 69
EPS in Rs 8.95 9.64 7.98 17.36 16.13 16.73 21.40 33.29 12.16 13.36
Dividend Payout % 171% 104% 125% 58% 124% 30% 117% 45% 148% 135%
Compounded Sales Growth
10 Years: %
5 Years: 7%
3 Years: 5%
TTM: 9%
Compounded Profit Growth
10 Years: %
5 Years: -3%
3 Years: -14%
TTM: 15%
Stock Price CAGR
10 Years: %
5 Years: 8%
3 Years: -21%
1 Year: 11%
Return on Equity
10 Years: %
5 Years: 21%
3 Years: 19%
Last Year: 13%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 51 54 54 54 53 53 53 53 53 53
Reserves 226 312 354 390 382 314 374 474 481 474
0 0 0 0 2 12 8 21 23 42
53 44 30 36 37 90 106 60 74 75
Total Liabilities 329 410 438 479 475 469 541 607 632 644
196 259 259 299 294 269 253 285 294 306
CWIP 6 1 17 0 1 5 8 3 2 3
Investments 86 93 104 120 95 90 126 146 144 162
42 56 58 60 84 105 154 173 192 173
Total Assets 329 410 438 479 475 469 541 607 632 644

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
34 68 90 107 100 168 115 113 129 168
-18 -18 -42 -43 -12 1 -49 -24 -39 -91
-23 -45 -49 -64 -94 -165 -62 -89 -86 -85
Net Cash Flow -6 5 -0 -0 -5 4 4 0 4 -8

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 10 11 8 10 11 14 33 58 59 28
Inventory Days 48 56 65 66 60 64 52 53 62 104
Days Payable 5 10 6 25 25 68 56 36 54 88
Cash Conversion Cycle 53 57 67 50 46 10 29 75 67 44
Working Capital Days 28 2 19 10 28 -5 21 44 36 107
ROCE % 24% 28% 33% 30% 35% 36% 42% 16% 18%

Shareholding Pattern

Numbers in percentages

3 Recently
Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
71.22% 71.18% 71.18% 71.18% 71.14% 71.14% 71.14% 71.14% 71.14% 71.11% 71.11% 71.11%
12.10% 12.02% 12.68% 12.82% 10.42% 10.13% 9.99% 3.44% 3.46% 3.35% 2.90% 2.49%
6.59% 6.71% 6.88% 7.15% 9.14% 8.68% 8.45% 13.46% 13.33% 13.89% 14.88% 14.89%
10.09% 10.09% 9.26% 8.85% 9.29% 10.04% 10.40% 11.95% 12.08% 11.64% 11.11% 11.49%
No. of Shareholders 62,93665,76966,31566,43171,41275,82274,38676,29272,00068,84464,82361,636

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls